Vimarsana
Biggest News Aggregation in the World

Page 4 - Kumar Budur News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kumar Budur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kumar Budur Today - Breaking & Trending Today

Harmony Biosciences (HRMY) Q3 2023 Earnings Call Transcript - Vimarsana News

Harmony Biosciences (HRMY) Q3 2023 Earnings Call Transcript

HRMY earnings call for the period ending September 30, 2023.

Source: fool.com
HARMONY BIOSCIENCES ANNOUNCES TOPLINE DATA FROM PHASE 3 INTUNE STUDY EVALUATING PITOLISANT IN PATIENTS WITH IDIOPATHIC HYPERSOMNIA - Vimarsana News

HARMONY BIOSCIENCES ANNOUNCES TOPLINE DATA FROM PHASE 3 INTUNE STUDY EVALUATING PITOLISANT IN PATIENTS WITH IDIOPATHIC HYPERSOMNIA

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and...

Harmony Biosciences stock drops on disappointing study results - Vimarsana News

Harmony Biosciences stock drops on disappointing study results

Harmony Biosciences Holdings Inc shares sank 38% to $18.66 in late-morning trading on Friday after the pharmaceutical company reported topline results from...

Pitolisant Looks Promising in Idiopathic Hypersomnia Study - Vimarsana News

Pitolisant Looks Promising in Idiopathic Hypersomnia Study

Treatment with pitolisant achieved robust clinical response in patients with idiopathic hypersomnia, according to phase 3 study results.

Source: empr.com
Pitolisant Misses Primary Endpoint in Phase 3 Study for IH - Vimarsana News

Pitolisant Misses Primary Endpoint in Phase 3 Study for IH

The INTUNE study of pitolisant for IH showed no statistical significance against placebo for daytime sleepiness in the withdrawal phase.